NASCAR Champion Kyle Busch Dies at 41 from Pneumonia and Sepsis Family Confirms European AI Trade Dependency Risk Report Warns of Dependency Trap with US and Asia Surging Gas Prices Disproportionately Burden LowIncome Households New York Fed Study Reveals Astera Labs Surges 32 Following Bullish Analyst Coverage Surging Gas Prices Disproportionately Squeeze LowerIncome Households New York Fed Study Suggests Professional Title Morgan Stanley Cuts Home Depot Price Target by 20 Amid Housing Headwinds WHWK Q1 2026 Earnings EPS Beat by 121 as Cost Discipline Gains Traction Exelixis Q1 2026 Earnings EPS Surprise Drives Modest Share Uptick SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise LGND Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Movement MasTec MTZ Q1 2026 Earnings EPS Surges 39 Above Estimates Stock Slips Despite Strong Beat CRM Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower BRC Inc BRCC Declines 257 as Shares Approach Key Support Level Haemonetics HAE Slips Modestly as Stock Tests Support Near 63 OLB Group Inc OLB Climbs Over 4 as Stock Approaches Key Resistance Level Energy Recovery Inc ERII Rises 267 as It Approaches Key Resistance at 929 Green Circle Decarbonize Technology GCDT Plunges 10 as Bears Test Critical Support Sun Pharma Reports 26 Profit Surge in Q4 FY2026 Proposes 5 Final Dividend AAON Q1 2026 Earnings Stellar EPS Beat Highlights Strong Execution Despite Stock Dip Nauticus Robotics Warrants KITTW Trade Sideways at 002 With Minimal Movement MKDWELL Tech Inc MKDW Surges 465 as Shares Test Key Resistance Near 852 Korn Ferry KFY Edges Higher Amid Consolidation Key Levels in Focus VLYPN Preferred Stock Maintains Stability Amid Modest Decline Creative Global Technology Holdings Limited CGTL Slips 6 as Stock Tests Key Support Levels Covista Inc CVSA Slides Marginally Holding Above Key Support NTRSO Holds Steady at 1870 as Support and Resistance Levels Define Trading Range Wave Life Sciences WVE Holds Near Support as Biotech Volatility Persists